Malignant fibrous histiocytoma in the craniocervical junction presenting with severe occipitalgia

被引:9
作者
Akai, Takuya
Yamamoto, Kenji
Iida, Takaaki
Iizuka, Hideaki
Nojima, Takayuki
机构
[1] Kanazawa Med Univ, Dept Neurosurg, Kaho Ku, Kanazawa, Ishikawa 9200293, Japan
[2] Kanazawa Med Univ, Dept Pathol, Kanazawa, Ishikawa, Japan
关键词
malignant fibrous histiocytoma; headache; chemotherapy; radiation;
D O I
10.1007/s10014-006-0202-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report a patient who complained of severe occipitalgia caused by destruction of the atlantooccipital joint by tumor invasion. Her symptoms were relieved by tumor resection and occipitocervical fixation. Histological examination of the resected tumor revealed that the tumor cells had an irregular arrangement, remarkable atypia, and pleomorphism with multinucleated bizarre giant cells. The tumor demonstrated no definitive sarcoma differentiation and was identified as malignant fibrous histiocytoma. After tumor resection, the patient received adjuvant radiation and chemotherapy. The tumor regrew outside the radiation field. Chemotherapy with ifosfamide, cisplatin, and etoposide caused remarkable tumor reduction, but suspension of chemotherapy resulted in tumor recurrence. The results of our drug protocol suggest that this regimen is feasible as postoperative adjuvant chemotherapy for malignant fibrous histiocytoma. The role of adjuvant chemotherapy and radiation therapy for this highly malignant rare tumor should be evaluated in a prospective study with precise histological diagnosis.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 34 条
[1]   Neck pain: Common complaint, uncommon diagnosis - Symptomatic clival chordoma [J].
Alvarado, R ;
Gomez, J ;
Morale, SG ;
Davis, CP .
SOUTHERN MEDICAL JOURNAL, 2004, 97 (01) :83-86
[2]   ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN IN HIGH-GRADE SOFT-TISSUE SARCOMA - A RANDOMIZED TRIAL OF THE SCANDINAVIAN-SARCOMA-GROUP [J].
ALVEGARD, TA ;
SIGURDSSON, H ;
MOURIDSEN, H ;
SOLHEIM, O ;
UNSGAARD, B ;
RINGBORG, U ;
DAHL, O ;
NORDENTOFT, AM ;
BLOMQVIST, C ;
RYDHOLM, A ;
STENER, B ;
RANSTAM, J .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1504-1513
[3]   AN INTERGROUP PHASE-III RANDOMIZED STUDY OF DOXORUBICIN AND DACARBAZINE WITH OR WITHOUT IFOSFAMIDE AND MESNA IN ADVANCED SOFT-TISSUE AND BONE SARCOMAS [J].
ANTMAN, K ;
CROWLEY, J ;
BALCERZAK, SP ;
RIVKIN, SE ;
WEISS, GR ;
ELIAS, A ;
NATALE, RB ;
COOPER, RM ;
BARLOGIE, B ;
TRUMP, DL ;
DOROSHOW, JH ;
AISNER, J ;
PUGH, RP ;
WEISS, RB ;
COOPER, BA ;
CLAMOND, GH ;
BAKER, LH .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1276-1285
[4]   Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: Results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen [J].
Bacci, G ;
Ferrari, S ;
Bertoni, F ;
Mercuri, M ;
Forni, C ;
Sottili, S ;
Gasbarrini, A ;
Tienghi, A ;
Cesari, M ;
Campanacci, M .
JOURNAL OF CHEMOTHERAPY, 1997, 9 (04) :293-299
[5]   ADJUVANT CYVADIC CHEMOTHERAPY FOR ADULT SOFT-TISSUE SARCOMA-REDUCED LOCAL RECURRENCE BUT NO IMPROVEMENT IN SURVIVAL - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER SOFT-TISSUE AND BONE SARCOMA GROUP [J].
BRAMWELL, V ;
ROUESSE, J ;
STEWARD, W ;
SANTORO, A ;
SCHRAFFORDTKOOPS, H ;
BUESA, J ;
RUKA, W ;
PRIARIO, J ;
WAGENER, T ;
BURGERS, M ;
VANUNNIK, J ;
CONTESSO, G ;
THOMAS, D ;
VANGLABBEKE, M ;
MARKHAM, D ;
PINEDO, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1137-1149
[6]   Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group [J].
Coindre, JM ;
Terrier, P ;
Bui, NB ;
Bonichon, F ;
Collin, F ;
LeDoussal, V ;
Mandard, AM ;
Vilain, MO ;
Jacquemier, J ;
Duplay, H ;
Sastre, X ;
Barlier, C ;
HenryAmar, M ;
Lesech, JM ;
Contesso, G .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :869-877
[7]  
Cormier JN, 2001, CANCER, V92, P1550, DOI 10.1002/1097-0142(20010915)92:6<1550::AID-CNCR1481>3.0.CO
[8]  
2-C
[9]   CHEMOTHERAPY OF MALIGNANT FIBROUS HISTIOCYTOMA OF BONE [J].
EARL, HM ;
PRINGLE, J ;
KEMP, H ;
MORITTU, L ;
MILES, D ;
SOUHAMI, R .
ANNALS OF ONCOLOGY, 1993, 4 (05) :409-415
[10]  
ELIAS AD, 1994, SEMIN ONCOL, V21, P76